Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Monitoring of Agitation Speed and RPM – V 2.0

Posted on By

Elixir Department: SOP for Monitoring of Agitation Speed and RPM – V 2.0

Standard Operating Procedure for Monitoring of Agitation Speed and RPM in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/094/2025
Supersedes SOP/ELX/094/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To establish a standardized procedure for monitoring and controlling agitation speed (RPM) during the manufacturing of elixir formulations to ensure proper mixing, homogeneity, and batch reproducibility.

2. Scope

This SOP applies to all mixing operations using mechanical stirrers or variable speed agitators in the Elixir Department during batch manufacturing.

3. Responsibilities

  • Production Operator:
    • Set and monitor agitation speed as per batch manufacturing record (BMR).
    • Record start and end RPM values and any variations.
  • Production Supervisor:
    • Ensure that set RPM parameters are followed and verified during in-process checks.
  • QA Officer:
    • Audit agitation logs and confirm speed consistency with validated parameters.
See also  Elixir Department: SOP for Preventive Maintenance of Mixing Vessels - V 2.0

4. Accountability

The Head of Production is accountable for ensuring that all agitation equipment is calibrated, RPM is correctly maintained, and documented in accordance with GMP requirements.

5. Procedure

5.1 Equipment Calibration and Verification

  1. Ensure the agitator RPM display is calibrated as per the annual calibration schedule.
  2. Verify the RPM reading at idle before starting the batch.
  3. Attach calibration label with due date visibly on the agitator panel.

5.2 Agitation Speed Setup

  1. Refer to the BMR or master formula to identify the required RPM range (e.g., 200–250 RPM).
  2. Set the desired RPM using the control panel on the agitator.
  3. Allow the agitator to run for 1–2 minutes to stabilize the speed before starting ingredient addition.

See also  Elixir Department: SOP for Statistical Trending of IPC Data - V 2.0

5.3 In-Process Monitoring

  1. Monitor RPM every 15–30 minutes or as specified in the BMR.
  2. Record the readings in the Agitation Monitoring Log (Annexure-1).
  3. Note any fluctuations above or below the specified range and notify the supervisor immediately.

5.4 Handling Deviations

  1. If deviation is less than ±5% of set RPM and stable, continue operation and record as minor deviation.
  2. If deviation is more than ±5% or fluctuates continuously, stop operation and escalate to engineering and QA.
  3. Document deviation details and corrective action in the Deviation Record.

5.5 Completion and Documentation

  1. Record final RPM at end of mixing and verify it matches with initial set value.
  2. Ensure the Agitation Monitoring Log is reviewed and signed by the supervisor.
  3. Attach the log to the BMR for QA review.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • RPM: Revolutions Per Minute
  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
See also  Elixir Department: SOP for Environmental Conditions for Dispensing of Elixirs - V 2.0

7. Documents

  1. Agitation Monitoring Log (Annexure-1)
  2. Deviation Record (if applicable)
  3. Batch Manufacturing Record (BMR)

8. References

  • 21 CFR Part 211.100 – Written Procedures; Deviations
  • WHO TRS 986 – GMP for Pharmaceutical Products
  • ICH Q8 – Pharmaceutical Development

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Agitation Monitoring Log

Date Batch No. Start RPM Mid-Process RPM End RPM Checked By Remarks
11/04/2025 ELX-1033 220 218 220 Rajesh Kumar Stable throughout

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP Release New SOP QA Head
11/04/2025 2.0 Added deviation thresholds and verification points GMP Enhancement QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Biosimilars: SOP for Monitoring and Logging of Critical Parameters – V 2.0
Next Post: API Manufacturing: SOP for SOP Writing, Review, and Approval – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version